Thinking outside the liver: Induced pluripotent stem cells for hepatic applications

World Journal of Gastroenterology

Volumn 19, Issue 22, 2013, Pages 3385-3396

  Subba Rao, Mekala ^a   Sasikala, Mitnala ^a   Reddy, D Nageshwar ^a  

^a ASIAN INSTITUTE OF GASTROENTEROLOGY   (India)

Author keywords

Clinical applications; Disease modeling; Drug toxicity; Hepatocytes; Liver stem cells; Patient specific induced pluripotent stem cell derived hepatocytes

Indexed keywords

ALPHA6 INTEGRIN; BETA1 INTEGRIN; KRUPPEL LIKE FACTOR 4; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; THY 1 ANTIGEN; TRANSCRIPTION FACTOR SOX2;

CELL DIFFERENTIATION; DNA FINGERPRINTING; FLOW CYTOMETRY; GENE MUTATION; HUMAN; IMMUNOCYTOCHEMISTRY; LIVER CELL; LONG TERMINAL REPEAT; NUCLEAR REPROGRAMMING; ONCOGENE C MYC; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TUMOR MICROENVIRONMENT;

EID: 84879036665     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i22.3385     Document Type: Review

References (112)

1. Jozefczuk J, Prigione A, Chavez L, Adjaye J. Comparative analysis of human embryonic stem cell and induced pluripo-tent stem cell-derived hepatocyte-like cells reveals current drawbacks and possible strategies for improved differentiation. Stem Cells Dev 2011; 20: 1259-1275. [DOI: 10.1089/scd.2010.0361]
2. Herrera MB, Bruno S, Buttiglieri S, Tetta C, Gatti S, Deregi-bus MC, Bussolati B, Camussi G. Isolation and characterization of a stem cell population from adult human liver. Stem Cells 2006; 24: 2840-2850. [DOI: 10.1634/ stemcells.2006-0114]
3. Lázaro CA, Rhim JA, Yamada Y, Fausto N. Generation of hepatocytes from oval cell precursors in culture. Cancer Res 1998; 58: 5514-5522.
4. Sahin MB, Schwartz RE, Buckley SM, Heremans Y, Chase L, Hu WS, Verfaillie CM. Isolation and characterization of a novel population of progenitor cells from unmanipulated rat liver. Liver Transpl 2008; 14: 333-345.
5. Czyz J, Wiese C, Rolletschek A, Blyszczuk P, Cross M, Wobus AM. Potential of embryonic and adult stem cells in vitro. Biol Chem 2003; 384: 1391-1409. [DOI: 10.1515/BC.2003.155]
6. Rashid ST, Corbineau S, Hannan N, Marciniak SJ, Miranda E, Alexander G, Huang-Doran I, Griffn J, Ahrlund-Richter L, Skepper J, Semple R, Weber A, Lomas DA, Vallier L. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest 2010; 120: 3127-3136. [DOI: 10.1172/JCI43122]
7. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fbroblast cultures by defned factors. Cell 2006; 126: 663-676. [DOI: 10.1016/j.cell.2006.07.024]
8. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fbroblasts by defned factors. Cell 2007; 131: 861-872. [DOI: 10.1016/j.cell.2007.11.019]
9. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA, Ruotti V, Stewart R, Slukvin II, Thomson JA. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007; 318: 1917-1920. [DOI: 10.1126/science.1151526]
10. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008; 451: 141-146. [DOI: 10.1038/na-ture06534]
11. Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimam-ura A, Lensch MW, Cowan C, Hochedlinger K, Daley GQ. Disease-specific induced pluripotent stem cells. Cell 2008; 134: 877-886. [DOI: 10.1016/j.cell.2008.07.041]
12. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsu-moto H, Chung W, Croft GF, Saphier G, Leibel R, Goland R, Wichterle H, Henderson CE, Eggan K. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008; 321: 1218-1221.[DOI: 10.1126/science.1158799]
13. Ye Z, Zhan H, Mali P, Dowey S, Williams DM, Jang YY, Dang CV, Spivak JL, Moliterno AR, Cheng L. Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 2009; 114: 5473-5480. [DOI: 10.1182/blood-2009-04-217406]
14. Raya A, Rodríguez-Pizà I, Guenechea G, Vassena R, Na-varro S, Barrero MJ, Consiglio A, Castellà M, Río P, Sleep E, González F, Tiscornia G, Garreta E, Aasen T, Veiga A, Verma IM, Surrallés J, Bueren J, Izpisúa Belmonte JC. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 2009; 460: 53-59. [DOI: 10.1038/nature08129]
15. Ku S, Soragni E, Campau E, Thomas EA, Altun G, Laurent LC, Loring JF, Napierala M, Gottesfeld JM. Friedreich's atax-ia induced pluripotent stem cells model intergenerational GAA·TTC triplet repeat instability. Cell Stem Cell 2010; 7: 631-637.
16. Lee G, Papapetrou EP, Kim H, Chambers SM, Tomishima MJ, Fasano CA, Ganat YM, Menon J, Shimizu F, Viale A, Tabar V, Sadelain M, Studer L. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 2009; 461: 402-406. [DOI: 10.1038/nature08320]
17. Ebert AD, Yu J, Rose FF, Mattis VB, Lorson CL, Thomson JA, Svendsen CN. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009; 457: 277-280. [DOI: 10.1038/nature07677]
18. Soldner F, Hockemeyer D, Beard C, Gao Q, Bell GW, Cook EG, Hargus G, Blak A, Cooper O, Mitalipova M, Isacson O, Jaenisch R. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009; 136: 964-977. [DOI: 10.1016/ j.cell.2009.02.013]
19. Ye L, Chang JC, Lin C, Sun X, Yu J, Kan YW. Induced plu-ripotent stem cells offer new approach to therapy in thalas-semia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc Natl Acad Sci USA 2009; 106: 9826-9830. [DOI: 10.1073/pnas.0904689106]
20. Carvajal-Vergara X, Sevilla A, D'Souza SL, Ang YS, Schaniel C, Lee DF, Yang L, Kaplan AD, Adler ED, Rozov R, Ge Y, Cohen N, Edelmann LJ, Chang B, Waghray A, Su J, Pardo S, Lichtenbelt KD, Tartaglia M, Gelb BD, Lemischka IR. Pa-tient-specifc induced pluripotent stem-cell-derived models of LEOPARD syndrome. Nature 2010; 465: 808-812. [DOI: 10.1038/nature09005]
21. Ghodsizadeh A, Taei A, Totonchi M, Seifnejad A, Gourabi H, Pournasr B, Aghdami N, Malekzadeh R, Almadani N, Salek-deh GH, Baharvand H. Generation of liver disease-specifc induced pluripotent stem cells along with effcient differentiation to functional hepatocyte-like cells. Stem Cell Rev 2010; 6: 622-632. [DOI: 10.1007/s12015-010-9189-3.]
22. Marchetto MC, Carromeu C, Acab A, Yu D, Yeo GW, Mu Y, Chen G, Gage FH, Muotri AR. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010; 143: 527-539. [DOI: 10.1016/j.cell.2010.10.016]
23. Zhang N, An MC, Montoro D, Ellerby LM. Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells. PLoS Curr 2010; 2: RRN1193. [DOI: 10.1371/currents.RRN1193]
24. Stojkovic M, Lako M, Strachan T, Murdoch A. Derivation, growth and applications of human embryonic stem cells. Reproduction 2004; 128: 259-267. [DOI: 10.1530/ rep.1.00243]
25. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-1147. [DOI: 10.1126/science.282.5391.1145]
26. Drukker M, Benvenisty N. The immunogenicity of human embryonic stem-derived cells. Trends Biotechnol 2004; 22: 136-141. [DOI: 10.1016/j.tibtech.2004.01.003]
27. Rhind SM, Taylor JE, De Sousa PA, King TJ, McGarry M, Wilmut I. Human cloning: can it be made safe? Nat Rev Genet 2003; 4: 855-864. [DOI: 10.1038/nrg1205]
28. Jaenisch R. Human cloning - the science and ethics of nuclear transplantation. N Engl J Med 2004; 351: 2787-2791.
29. Cowan CA, Atienza J, Melton DA, Eggan K. Nuclear repro-gramming of somatic cells after fusion with human embryonic stem cells. Science 2005; 309: 1369-1373. [DOI: 10.1126/science.1116447]
30. Tada M, Takahama Y, Abe K, Nakatsuji N, Tada T. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol 2001; 11: 1553-1558. [DOI: 10.1016/S0960-9822(01)00459-6]
31. Yoshida Y, Yamanaka S. iPS cells: a source of cardiac regeneration. J Mol Cell Cardiol 2011; 50: 327-332. [DOI: 10.1016/j.yjmcc.2010.10.026]
32. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007; 448: 313-317. [DOI: 10.1038/nature05934]
33. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborne CS, Pawliuk R, Morillon E, Sorensen R, Forster A, Fraser P, Cohen JI, de Saint Basile G, Alexander I, Wintergerst U, Frebourg T, Au-rias A, Stoppa-Lyonnet D, Romana S, Radford-Weiss I, Gross F, Valensi F, Delabesse E, Macintyre E, Sigaux F, Soulier J, Leiva LE, Wissler M, Prinz C, Rabbitts TH, Le Deist F, Fischer A, Cavazzana-Calvo M. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415-419.
34. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 2008; 322: 945-949.
35. Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M. Ef-fcient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci 2009; 85: 348-362. [DOI: 10.2183/pjab.85.348]
36. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008; 322: 949-953. [DOI: 10.1126/science.1164270]
37. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, Slukvin II, Thomson JA. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009; 324: 797-801. [DOI: 10.1126/science.1172482]
38. Zhou H, Wu S, Joo JY, Zhu S, Han DW, Lin T, Trauger S, Bien G, Yao S, Zhu Y, Siuzdak G, Schöler HR, Duan L, Ding S. Generation of induced pluripotent stem cells using recombi-nant proteins. Cell Stem Cell 2009; 4: 381-384. [DOI: 10.1016/j.stem.2009.04.005]
39. Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, Chen AE, Melton DA. Induction of pluripotent stem cells by defned factors is greatly improved by small-molecule compounds. Nat Biotechnol 2008; 26: 795-797. [DOI: 10.1038/nbt1418]
40. Warren L, Manos PD, Ahfeldt T, Loh YH, Li H, Lau F, Ebina W, Mandal PK, Smith ZD, Meissner A, Daley GQ, Brack AS, Collins JJ, Cowan C, Schlaeger TM, Rossi DJ. Highly effcient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010; 7: 618-630. [DOI: 10.1016/ j.stem.2010.08.012]
41. Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, Arnold K, Stadtfeld M, Yachechko R, Tchieu J, Jaenisch R, Plath K, Hochedlinger K. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 2007; 1: 55-70. [DOI: 10.1016/j.stem.2007.05.014]
42. Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K, Bernstein BE, Jaenisch R. In vitro repro-gramming of fbroblasts into a pluripotent ES-cell-like state. Nature 2007; 448: 318-324. [DOI: 10.1038/na-ture05944]
43. Sommer CA, Stadtfeld M, Murphy GJ, Hochedlinger K, Kotton DN, Mostoslavsky G. Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 2009; 27: 543-549. [DOI: 10.1634/stem-cells.2008-1075]
44. Sommer CA, Sommer AG, Longmire TA, Christodoulou C, Thomas DD, Gostissa M, Alt FW, Murphy GJ, Kotton DN, Mostoslavsky G. Excision of reprogramming transgenes improves the differentiation potential of iPS cells generated with a single excisable vector. Stem Cells 2010; 28: 64-74. [DOI: 10.1002/stem.255]
45. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009; 458: 771-775. [DOI: 10.1038/nature07864]
46. Woltjen K, Michael IP, Mohseni P, Desai R, Mileikovsky M, Hämäläinen R, Cowling R, Wang W, Liu P, Gertsen-stein M, Kaji K, Sung HK, Nagy A. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009; 458: 766-770. [DOI: 10.1038/na-ture07863]
47. Brambrink T, Foreman R, Welstead GG, Lengner CJ, Wernig M, Suh H, Jaenisch R. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2008; 2: 151-159. [DOI: 10.1016/j.stem.2008.01.004]
48. Maherali N, Ahfeldt T, Rigamonti A, Utikal J, Cowan C, Hochedlinger K. A high-effciency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 2008; 3: 340-345. [DOI: 10.1016/ j.stem.2008.08.003]
49. Wernig M, Lengner CJ, Hanna J, Lodato MA, Steine E, Foreman R, Staerk J, Markoulaki S, Jaenisch R. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat Biotechnol 2008; 26: 916-924. [DOI: 10.1038/nbt1483]
50. Okita K, Yamanaka S. Induction of pluripotency by defned factors. Exp Cell Res 2010; 316: 2565-2570.
51. Hussein SM, Nagy K, Nagy A. Human induced pluripotent stem cells: the past, present, and future. Clin Pharmacol Ther 2011; 89: 741-745. [DOI: 10.1038/clpt.2011.37]
52. Jia F, Wilson KD, Sun N, Gupta DM, Huang M, Li Z, Panetta NJ, Chen ZY, Robbins RC, Kay MA, Longaker MT, Wu JC. A nonviral minicircle vector for deriving human iPS cells. Nat Methods 2010; 7: 197-199. [DOI: 10.1038/ nmeth.1426]
53. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N, Yamanaka S. Generation of induced pluripotent stem cells without Myc from mouse and human fbroblasts. Nat Biotechnol 2008; 26: 101-106. [DOI: 10.1038/nbt1374]
54. Wernig M, Meissner A, Cassady JP, Jaenisch R. c-Myc is dispensable for direct reprogramming of mouse fbroblasts. Cell Stem Cell 2008; 2: 10-12. [DOI: 10.1016/ j.stem.2007.12.001]
55. Kim JB, Zaehres H, Wu G, Gentile L, Ko K, Sebastiano V, Araúzo-Bravo MJ, Ruau D, Han DW, Zenke M, Schöler HR. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 2008; 454: 646-650. [DOI: 10.1038/nature07061]
56. Kim JB, Sebastiano V, Wu G, Araúzo-Bravo MJ, Sasse P, Gentile L, Ko K, Ruau D, Ehrich M, van den Boom D, Meyer J, Hübner K, Bernemann C, Ortmeier C, Zenke M, Fleis-chmann BK, Zaehres H, Schöler HR. Oct4-induced pluripo-tency in adult neural stem cells. Cell 2009; 136: 411-419. [DOI: 10.1016/j.cell.2009.01.023]
57. Medvedev SP, Shevchenko AI, Mazurok NA, Zakiian SM. [OCT4 and NANOG are the key genes in the system of pluripotency maintenance in mammalian cells]. Gene-tika 2008; 44: 1589-1608. [DOI: 10.1134/ S1022795408120016]
58. Masui S, Nakatake Y, Toyooka Y, Shimosato D, Yagi R, Takahashi K, Okochi H, Okuda A, Matoba R, Sharov AA, Ko MS, Niwa H. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol 2007; 9: 625-635. [DOI: 10.1038/ncb1589]
59. Shevchenko AI, Medvedev SP, Mazurok NA, Zakiian SM. Induced pluripotent stem cells. Russ J Genet 2009; 45: 139-146. [DOI: 10.1134/S1022795409020021]
60. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell-Badge R. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 2003; 17: 126-140. [DOI: 10.1101/gad.224503]
61. Rowland BD, Bernards R, Peeper DS. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol 2005; 7: 1074-1082. [DOI: 10.1038/ncb1314]
62. Lin T, Chao C, Saito S, Mazur SJ, Murphy ME, Appella E, Xu Y. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 2005; 7: 165-171. [DOI: 10.1038/ncb1211]
63. Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell 2007; 1: 39-49. [DOI: 10.1016/j.stem. 2007.05.012]
64. Field M, Alvarez A, Bushnev S, Sugaya K. Embryonic stem cell markers distinguishing cancer stem cells from normal human neuronal stem cell populations in malignant glioma patients. Clin Neurosurg 2010; 57: 151-159.
65. Büssing I, Slack FJ, Grosshans H. let-7 microRNAs in development, stem cells and cancer. Trends Mol Med 2008; 14: 400-409. [DOI: 10.1016/j.molmed.2008.07.001]
66. Viswanathan SR, Daley GQ, Gregory RI. Selective blockade of microRNA processing by Lin28. Science 2008; 320: 97-100.
67. Banito A, Rashid ST, Acosta JC, Li S, Pereira CF, Geti I, Pinho S, Silva JC, Azuara V, Walsh M, Vallier L, Gil J. Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev 2009; 23: 2134-2139. [DOI: 10.1101/gad.1811609]
68. Li H, Collado M, Villasante A, Strati K, Ortega S, Cañamero M, Blasco MA, Serrano M. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 2009; 460: 1136-1139. [DOI: 10.1038/nature08290]
69. Utikal J, Polo JM, Stadtfeld M, Maherali N, Kulalert W, Walsh RM, Khalil A, Rheinwald JG, Hochedlinger K. Immortalization eliminates a roadblock during cellular repro-gramming into iPS cells. Nature 2009; 460: 1145-1148. [DOI: 10.1038/nature08285]
70. Zaehres H, Kim JB, Schöler HR. Induced pluripotent stem cells. Methods Enzymol 2010; 476: 309-325.
71. Ohnuki M, Takahashi K, Yamanaka S. Generation and characterization of human induced pluripotent stem cells. Curr Protoc Stem Cell Biol 2009; Chapter 4: Unit 4A.2. [DOI: 10.1002/9780470151808.sc04a02s9]
72. Chang KH, Nelson AM, Fields PA, Hesson JL, Ulyanova T, Cao H, Nakamoto B, Ware CB, Papayannopoulou T. Diverse hematopoietic potentials of fve human embryonic stem cell lines. Exp Cell Res 2008; 314: 2930-2940. [DOI: 10.1016/j.yexcr.2008.07.019]
73. Mikkola M, Olsson C, Palgi J, Ustinov J, Palomaki T, Horel-li-Kuitunen N, Knuutila S, Lundin K, Otonkoski T, Tuuri T. Distinct differentiation characteristics of individual human embryonic stem cell lines. BMC Dev Biol 2006; 6: 40. [DOI: 10.1186/1471-213X-6-40]
74. Buchholz DE, Hikita ST, Rowland TJ, Friedrich AM, Hin-man CR, Johnson LV, Clegg DO. Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells 2009; 27: 2427-2434. [DOI: 10.1002/stem.189]
75. Andersson TB, Sundberg MI. Livers cells derived from human embryonic stem cells Progress and potential use in ADMET applications. Drug Discov Today: Technol 2008; 5: e143-e147. [DOI: 10.1016/j.ddtec.2008.09.001]
76. Agarwal S, Holton KL, Lanza R. Efficient differentiation of functional hepatocytes from human embryonic stem cells. Stem Cells 2008; 26: 1117-1127. [DOI: 10.1634/stemcells.2007-1102]
77. Basma H, Soto-Gutiérrez A, Yannam GR, Liu L, Ito R, Yama-moto T, Ellis E, Carson SD, Sato S, Chen Y, Muirhead D, Navarro-Alvarez N, Wong RJ, Roy-Chowdhury J, Platt JL, Mercer DF, Miller JD, Strom SC, Kobayashi N, Fox IJ. Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology 2009; 136: 990-999. [DOI: 10.1053/j.gastro.2008.10.047]
78. Sullivan GJ, Hay DC, Park IH, Fletcher J, Hannoun Z, Payne CM, Dalgetty D, Black JR, Ross JA, Samuel K, Wang G, Daley GQ, Lee JH, Church GM, Forbes SJ, Iredale JP, Wilmut I. Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology 2010; 51: 329-335. [DOI: 10.1002/hep.23335]
79. Song Z, Cai J, Liu Y, Zhao D, Yong J, Duo S, Song X, Guo Y, Zhao Y, Qin H, Yin X, Wu C, Che J, Lu S, Ding M, Deng H. Effcient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res 2009; 19: 1233-1242. [DOI: 10.1038/cr.2009.107]
80. Si-Tayeb K, Noto FK, Nagaoka M, Li J, Battle MA, Duris C, North PE, Dalton S, Duncan SA. Highly effcient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 2010; 51: 297-305. [DOI: 10.1002/hep.23354]
81. Liu H, Ye Z, Kim Y, Sharkis S, Jang YY. Generation of endo-derm-derived human induced pluripotent stem cells from primary hepatocytes. Hepatology 2010; 51: 1810-1819. [DOI: 10.1002/hep.23626]
82. Takata A, Otsuka M, Kogiso T, Kojima K, Yoshikawa T, Tateishi R, Kato N, Shiina S, Yoshida H, Omata M, Koike K. Direct differentiation of hepatic cells from human induced pluripotent stem cells using a limited number of cytokines. Hepatol Int 2011 Feb 6 [Epub ahead of print]. [DOI: 10.1007/s12072-011-9251-5]
83. Gai H, Nguyen DM, Moon YJ, Aguila JR, Fink LM, Ward DC, Ma Y. Generation of murine hepatic lineage cells from induced pluripotent stem cells. Differentiation 2010; 79: 171-181. [DOI: 10.1016/j.diff.2010.01.002]
84. Iwamuro M, Komaki T, Kubota Y, Seita M, Kawamoto H, Yuasa T, Shahid JM, Hassan RA, Hassan WA, Nakaji S, Nishikawa Y, Kondo E, Yamamoto K, Fox IJ, Kobayashi N. Hepatic differentiation of mouse iPS cells in vitro. Cell Transplant 2010; 19: 841-847. [DOI: 10.3727/096368 910X508960]
85. Gómez-Lechón MJ, Donato MT, Castell JV, Jover R. Human hepatocytes as a tool for studying toxicity and drug metabolism. Curr Drug Metab 2003; 4: 292-312.
86. Rao MS, Khan AA, Parveen N, Habeeb MA, Habibullah CM, Pande G. Characterization of hepatic progenitors from human fetal liver during second trimester. World J Gastro-enterol 2008; 14: 5730-5737. [DOI: 10.3748/ wjg.14.5730]
87. Wilkening S, Stahl F, Bader A. Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metab Dispos 2003; 31: 1035-1042. [DOI: 10.1124/ dmd.31.8.1035]
88. Seifinejad A, Tabebordbar M, Baharvand H, Boyer LA, Salekdeh GH. Progress and promise towards safe induced pluripotent stem cells for therapy. Stem Cell Rev 2010; 6: 297-306. [DOI: 10.1007/s12015-010-9121-x]
89. Andrade RJ, Robles M, Fernández-Castañer A, López-Ortega S, López-Vega MC, Lucena MI. Assessment of drug-induced hepatotoxicity in clinical practice: a challenge for gastroenterologists. World J Gastroenterol 2007; 13: 329-340.
90. Dekant W. The role of biotransformation and bioactivation in toxicity. EXS 2009; 99: 57-86. [DOI: 10.100 7/978-3-7643-8336-7_3]
91. Greenhough S, Medine CN, Hay DC. Pluripotent stem cell derived hepatocyte like cells and their potential in toxicity screening. Toxicology 2010; 278: 250-255. [DOI: 10.1016/j.tox.2010.07.012]
92. Miura K, Okada Y, Aoi T, Okada A, Takahashi K, Okita K, Nakagawa M, Koyanagi M, Tanabe K, Ohnuki M, Ogawa D, Ikeda E, Okano H, Yamanaka S. Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol 2009; 27: 743-745. [DOI: 10.1038/nbt.1554]
93. Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, Kim J, Aryee MJ, Ji H, Ehrlich LI, Yabuuchi A, Takeuchi A, Cunniff KC, Hongguang H, McKinney-Freeman S, Naveiras O, Yoon TJ, Irizarry RA, Jung N, Seita J, Hanna J, Murakami P, Jaenisch R, Weissleder R, Orkin SH, Weissman IL, Feinberg AP, Daley GQ. Epigenetic memory in induced pluripotent stem cells. Nature 2010; 467: 285-290. [DOI: 10.1038/na-ture09342]
94. Polo JM, Liu S, Figueroa ME, Kulalert W, Eminli S, Tan KY, Apostolou E, Stadtfeld M, Li Y, Shioda T, Natesan S, Wagers AJ, Melnick A, Evans T, Hochedlinger K. Cell type of origin infuences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol 2010; 28: 848-855. [DOI: 10.1038/nbt.1667]
95. Espejel S, Roll GR, McLaughlin KJ, Lee AY, Zhang JY, Laird DJ, Okita K, Yamanaka S, Willenbring H. Induced pluripo-tent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice. J Clin Invest 2010; 120: 3120-3126. [DOI: 10.1172/JCI43267]
96. Fausto N. Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology 2004; 39: 1477-1487. [DOI: 10.1002/hep.20214]
97. Schmelzer E, Wauthier E, Reid LM. The phenotypes of pluripotent human hepatic progenitors. Stem Cells 2006; 24: 1852-1858. [DOI: 10.1634/stemcells.2006-0036]
98. Roskams TA, Theise ND, Balabaud C, Bhagat G, Bhathal PS, Bioulac-Sage P, Brunt EM, Crawford JM, Crosby HA, Desmet V, Finegold MJ, Geller SA, Gouw AS, Hytiroglou P, Knisely AS, Kojiro M, Lefkowitch JH, Nakanuma Y, Olynyk JK, Park YN, Portmann B, Saxena R, Scheuer PJ, Strain AJ, Thung SN, Wanless IR, West AB. Nomenclature of the fner branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology 2004; 39: 1739-1745. [DOI: 10.1002/hep.20130]
99. Terrace JD, Currie IS, Hay DC, Masson NM, Anderson RA, Forbes SJ, Parks RW, Ross JA. Progenitor cell characterization and location in the developing human liver. Stem Cells Dev 2007; 16: 771-778.
100. Khan AA, Shaik MV, Parveen N, Rajendraprasad A, Aleem MA, Habeeb MA, Srinivas G, Raj TA, Tiwari SK, Kumaresan K, Venkateswarlu J, Pande G, Habibullah CM. Human fetal liver-derived stem cell transplantation as supportive modality in the management of end-stage decompensated liver cirrhosis. Cell Transplant 2010; 19: 409-418.
101. Challen GA, Little MH. A side order of stem cells: the SP phenotype. Stem Cells 2006; 24: 3-12. [DOI: 10.1634/stemcells.2005-0116]
102. Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, Boggs SS, Greenberger JS, Goff JP. Bone marrow as a potential source of hepatic oval cells. Science 1999; 284: 1168-1170.
103. Theise ND, Nimmakayalu M, Gardner R, Illei PB, Morgan G, Teperman L, Henegariu O, Krause DS. Liver from bone marrow in humans. Hepatology 2000; 32: 11-16. [DOI: 10.1053/jhep.2000.9124]
104. Houlihan DD, Newsome PN. Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroenterology 2008; 135: 438-450. [DOI: 10.1053/j.gastro. 2008.05.040]
105. He ZP, Tan WQ, Tang YF, Zhang HJ, Feng MF. Activation, isolation, identification and in vitro proliferation of oval cells from adult rat livers. Cell Prolif 2004; 37: 177-187. [DOI: 10.1111/j.1365-2184.2004.00293.x]
106. Petersen BE, Goff JP, Greenberger JS, Michalopoulos GK. Hepatic oval cells express the hematopoietic stem cell marker Thy-1 in the rat. Hepatology 1998; 27: 433-445. [DOI: 10.1002/hep.510270218]
107. Hatch HM, Zheng D, Jorgensen ML, Petersen BE. SDF-1alpha/CXCR4: a mechanism for hepatic oval cell activation and bone marrow stem cell recruitment to the injured liver of rats. Cloning Stem Cells 2002; 4: 339-351. [DOI: 10.1089/153623002321025014]
108. Sharma AD, Cantz T, Manns MP, Ott M. The role of stem cells in physiology, pathophysiology, and therapy of the liver. Stem Cell Rev 2006; 2: 51-58. [DOI: 10.1007/s12015-006-0009-8]
109. Vierbuchen T, Ostermeier A, Pang ZP, Kokubu Y, Südhof TC, Wernig M. Direct conversion of fbroblasts to functional neurons by defined factors. Nature 2010; 463: 1035-1041. [DOI: 10.1038/nature08797]
110. Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau BG, Srivastava D. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010; 142: 375-386. [DOI: 10.1016/ j.cell.2010.07.002]
111. Szabo E, Rampalli S, Risueño RM, Schnerch A, Mitchell R, Fiebig-Comyn A, Levadoux-Martin M, Bhatia M. Direct conversion of human fbroblasts to multilineage blood progenitors. Nature 2010; 468: 521-526. [DOI: 10.1038/nature09591]
112. Huang P, He Z, Ji S, Sun H, Xiang D, Liu C, Hu Y, Wang X, Hui L. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature 2011; 475: 386-389. [DOI: 10.1038/nature10116]